Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Adlai Nortye Ltd ADR (ANL)

Adlai Nortye Ltd ADR (ANL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adlai Nortye Ltd ADR UGLAND HOUSE PO BOX 309 GRAND CAYMAN E9 KY1-1104 CYM

www.adlainortye.com Employees: 123 P: 848-230-7430

Sector:

Medical

Description:

Adlai Nortye Ltd. is a clinical-stage biotechnology company. It focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. Adlai Nortye Ltd. is based in SINGAPORE.

Key Statistics

Overview:

Market Capitalization, $K 363,834
Enterprise Value, $K 329,264
Shares Outstanding, K 36,900
Float, K 36,900
% Float 100.00%
Short Interest, K 758
Short Float 2.05%
Days to Cover 1.00
Short Volume Ratio 0.42
% of Institutional Shareholders 35.21%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -51,870 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -63,397 K
EBIT, $ 0 K
EBITDA, $ -51,930 K

Growth:

1-Year Return 345.87%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/29/26
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 5.56
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 44.81
Book Value/Share 0.21
Interest Coverage -25.74
60-Month Beta -1.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar